Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Front Immunol ; 12: 740047, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34659232

RESUMO

Thymic epithelial cells (TECs) are essential in supporting the development of mature T cells from hematopoietic progenitor cells and facilitate their lineage-commitment, proliferation, T-cell receptor repertoire selection and maturation. While animal model systems have greatly aided in elucidating the contribution of stromal cells to these intricate processes, human tissue has been more difficult to study, partly due to a lack of suitable surface markers comprehensively defining human TECs. Here, we conducted a flow cytometry based surface marker screen to reliably identify and quantify human TECs and delineate medullary from cortical subsets. These findings were validated by transcriptomic and histologic means. The combination of EpCAM, podoplanin (pdpn), CD49f and CD200 comprehensively identified human TECs and not only allowed their reliable distinction in medullary and cortical subsets but also their detailed quantitation. Transcriptomic profiling of each subset in comparison to fibroblasts and endothelial cells confirmed the identity of the different stromal cell subsets sorted according to the proposed strategy. Our dataset not only demonstrated transcriptional similarities between TEC and cells of mesenchymal origin but furthermore revealed a subset-specific distribution of a specific set of extracellular matrix-related genes in TECs. This indicates that TECs significantly contribute to the distinct compartmentalization - and thus function - of the human thymus. We applied the strategy to quantify TEC subsets in 31 immunologically healthy children, which revealed sex-specific differences of TEC composition early in life. As the distribution of mature CD4- or CD8-single-positive thymocytes was correspondingly altered, the composition of the thymic epithelial compartment may directly impact on the CD4-CD8-lineage choice of thymocytes. We prove that the plain, reliable strategy proposed here to comprehensively identify human TEC subpopulations by flow cytometry based on surface marker expression is suitable to determine their frequency and phenotype in health and disease and allows sorting of live cells for downstream analysis. Its use reaches from a reliable diagnostic tool for thymic biopsies to improved phenotypic characterization of thymic grafts intended for therapeutic use.


Assuntos
Separação Celular , Células Epiteliais/metabolismo , Citometria de Fluxo , Perfilação da Expressão Gênica , Células Estromais/metabolismo , Timo/metabolismo , Transcriptoma , Síndrome da Deleção 22q11/genética , Síndrome da Deleção 22q11/imunologia , Síndrome da Deleção 22q11/metabolismo , Adolescente , Fatores Etários , Biomarcadores/metabolismo , Criança , Pré-Escolar , Deleção Cromossômica , Cromossomos Humanos Par 22 , Células Epiteliais/imunologia , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Miastenia Gravis/genética , Miastenia Gravis/imunologia , Miastenia Gravis/metabolismo , Fenótipo , Fatores Sexuais , Células Estromais/imunologia , Timo/citologia , Timo/imunologia
2.
Brain ; 144(5): 1351-1360, 2021 06 22.
Artigo em Inglês | MEDLINE | ID: mdl-33876226

RESUMO

Neuroimmune dysregulation is implicated in neuropsychiatric disorders including schizophrenia. As the blood-brain barrier is the immunological interface between the brain and the periphery, we investigated whether this vascular phenotype is intrinsically compromised in the most common genetic risk factor for schizophrenia, the 22q11.2 deletion syndrome (22qDS). Blood-brain barrier like endothelium differentiated from human 22qDS+schizophrenia-induced pluripotent stem cells exhibited impaired barrier integrity, a phenotype substantiated in a mouse model of 22qDS. The proinflammatory intercellular adhesion molecule-1 was upregulated in 22qDS+schizophrenia-induced blood-brain barrier and in 22qDS mice, indicating compromise of the blood-brain barrier immune privilege. This immune imbalance resulted in increased migration/activation of leucocytes crossing the 22qDS+schizophrenia blood-brain barrier. We also found heightened astrocyte activation in murine 22qDS, suggesting that the blood-brain barrier promotes astrocyte-mediated neuroinflammation. Finally, we substantiated these findings in post-mortem 22qDS brain tissue. Overall, the barrier-promoting and immune privilege properties of the 22qDS blood-brain barrier are compromised, and this might increase the risk for neuropsychiatric disease.


Assuntos
Síndrome da Deleção 22q11/patologia , Barreira Hematoencefálica/patologia , Síndrome da Deleção 22q11/imunologia , Animais , Astrócitos/metabolismo , Humanos , Privilégio Imunológico/fisiologia , Inflamação/metabolismo , Camundongos
3.
Allergol. immunopatol ; 49(1): 95-100, ene.-feb. 2021. tab
Artigo em Inglês | IBECS | ID: ibc-199231

RESUMO

INTRODUCTION AND OBJECTIVES: The purpose of this study was to evaluate patients diagnosed with 22q11.2 deletion syndrome and determine the clues directing to diagnosis and evaluation of immunological findings for excellent management of the disease. MATERIAL AND METHODS: Thirty-three pediatric patients with 22q11.2 deletion syndrome diag­nosed between 1998 and 2019 at Pediatric Immunology Division of Ege University Faculty of Medicine and SBU Izmir Dr Behcet Uz Children's Education and Research Hospital were evaluated. RESULTS: This study includes the largest case series reported from Turkey. Congenital car­diac anomalies were the most common pathology associated with the syndrome (90.9%). Hypocalcemic symptoms were observed in 13 patients (40%). Twenty-two of the 33 (66.6%) patients were diagnosed before two years of age. Autoimmune diseases, dysmorphic facial findings, recurrent infections, growth retardation, and speech impairment were other clues for diagnosis in older patients. Clinical spectrum and immunological abnormalities of this syn­drome are quite variable. All T-cell subset counts were less than 5th percentile below median by age in one patient (3%) and 10 patients had normal all T-cell subset counts (30.3%). Overall, 69.6% of the patients had normal IgG, IgA, and IgM levels and two patients had panhypogam­maglobulinemia. Recurrent infections were revealed in 75.7% of the patients during follow-up. CONCLUSIONS: Presence of cardiac anomaly is more helpful in the diagnosis, especially under two years of age. Patients with immunologically high or standard risk did not show any differ­ence in terms of numbers and severity of infections and autoimmunity


No disponible


Assuntos
Humanos , Masculino , Feminino , Pré-Escolar , Síndrome da Deleção 22q11/diagnóstico , Síndromes de Imunodeficiência/epidemiologia , Síndromes de Imunodeficiência/imunologia , Transtornos Cromossômicos/epidemiologia , Cromossomos Humanos Par 22 , Síndrome da Deleção 22q11/imunologia , Doenças do Sistema Imunitário/diagnóstico , Doenças do Sistema Imunitário/imunologia , Testes Imunológicos , Técnicas Imunológicas/métodos , Doenças Autoimunes/diagnóstico , Doenças Autoimunes/imunologia
4.
Clin Immunol ; 220: 108590, 2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-32920211

RESUMO

22q11.2 deletion syndrome (22q11.2DS) has a heterogeneous presentation that includes multiple congenital anomalies and immunodeficiency, one of the most striking features. Usually, it is characterized by T cell lymphopenia, B cell dysfunction and autoimmunity. Here, we describe an unusual case of 22q11.2DS in a patient with lymphoproliferative disorder, polyautoimmunity and hypogammaglobulinemia.


Assuntos
Síndrome da Deleção 22q11/complicações , Agamaglobulinemia/etiologia , Transtornos Linfoproliferativos/etiologia , Síndrome da Deleção 22q11/imunologia , Adolescente , Agamaglobulinemia/imunologia , Autoimunidade , Feminino , Humanos , Transtornos Linfoproliferativos/imunologia
6.
Mol Genet Genomic Med ; 8(1): e1057, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-31830774

RESUMO

BACKGROUND: The 22q11.2 deletion syndrome (22q11.2DS) is the most common contiguous microdeletion affecting humans and exhibits extreme phenotypic heterogeneity. Patients can manifest any combination of comorbidities including congenital heart disease, hypoparathyroidism, cleft palate, kidney abnormalities, neurodevelopmental disorders, and immune dysfunction. Immunodeficiency is present in the majority of patients with 22q11.2DS and is the second leading cause of death in these patients. Knowing the genetic determinants of immune dysfunction will aid in prognostication and potentially novel treatments. METHODS: We performed exome sequencing and gene-based variant association analysis on 31 deeply phenotyped individuals with the canonical 3Mb 22q11.2 deletion to identify what genes outside the 22q11.2 locus may be modifying the immune dysregulated phenotype. Immunophenotyping was performed using preexisting medical data and a novel scoring system developed from numerous clinical laboratory values including immunoglobulin levels, lymphocyte transformation to antigens (LTA), lymphocyte transformation to mitogens (LTM), and peripheral blood flow cytometry. Immunophenotypic scoring was validated against newborn screening T-cell receptor excision circle (TREC) results. RESULTS: Rare DNA variants in transcriptional regulators involved in retinoic acid signaling (NCOR2, OMIM *600848 and EP300, OMIM *602700) were found to be associated with immunophenotype. CONCLUSION: The expression of TBX1, which seems to confer the major phenotypic features of 22q11.2DS, is regulated via retinoic acid signaling, and alterations in retinoic acid signaling during embryonic development can lead to phenocopies of 22q11.2DS. These observations support the hypothesis that genetic modifiers outside the microdeletion locus may influence the immune function in 22q11.2DS patients.


Assuntos
Síndrome da Deleção 22q11/genética , Genes Modificadores , Linfócitos/imunologia , Síndrome da Deleção 22q11/imunologia , Proteína p300 Associada a E1A/genética , Humanos , Imunofenotipagem , Correpressor 2 de Receptor Nuclear/genética , Fenótipo
9.
Curr Opin Pediatr ; 25(6): 730-5, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24136300

RESUMO

PURPOSE OF REVIEW: 22q11 deletion syndrome is the most common genetic abnormality. More patients are surviving cardiac surgery, and many do not have cardiac anomalies. Adult patients are now being described. It is important for paediatricians, and increasingly adult physicians, to be aware of the optimum management of these patients. RECENT FINDINGS: Three main immunological patterns are recognized, namely, athymic and incomplete 22q11 deletion syndrome and autoimmunity. Newborn screening for severe combined immunodeficiency detects athymic patients, although diagnosis may be complicated, and instructive cases are described. Incomplete 22q11 deletion syndrome is the most common presentation; new findings predict which patients are likely to experience significant infection. B lymphocyte deficiencies are often overlooked. Data regarding autoimmunity in adult patients is reported, as well as newly reported immunological findings. Finally, management guidelines are now published, and these are highlighted. SUMMARY: Newborn screening detects patients with athymic 22q11 deletion syndrome, but significant illness may complicate the picture, and dual diagnoses can confound treatment. Treatment options for these patients are becoming clearer. Hypoparathyroidism is associated with more severe infection, and immunoglobulin abnormalities are more common than previously recognized. Adult patients are symptomatic and management guidelines will help general physicians in managing these patients.


Assuntos
Síndrome da Deleção 22q11/imunologia , Cardiopatias Congênitas/imunologia , Transplante de Células-Tronco Hematopoéticas/métodos , Hipoparatireoidismo/imunologia , Triagem Neonatal , Timo/transplante , Síndrome da Deleção 22q11/genética , Síndrome da Deleção 22q11/patologia , Adolescente , Adulto , Fatores Etários , Tolerância Central , Criança , Pré-Escolar , Feminino , Predisposição Genética para Doença , Testes Genéticos , Cardiopatias Congênitas/genética , Cardiopatias Congênitas/patologia , Humanos , Lactente , Recém-Nascido , Masculino , Guias de Prática Clínica como Assunto , Linfócitos T/imunologia , Timo/imunologia , Timo/patologia
10.
Eur J Endocrinol ; 165(2): 345-52, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21606191

RESUMO

OBJECTIVE: To characterize the endocrine and autoimmune disturbances with emphasis on parathyroid dysfunction in patients with 22q11.2 deletion syndrome (22q11.2 DS). Design In this nationwide survey; 59 patients (age 1-54 years) out of 86 invited with a 22q11.2 DS were recruited through all the genetic institutes in Norway. METHODS: Data was collected from blood tests, medical records, a physical examination and a semi-structured interview. We registered autoimmune diseases and measured autoantibodies, hormone levels and HLA types. RESULTS: Twenty-eight (47%) patients had hypoparathyroidism or a history of neonatal or transient hypocalcemia. Fifteen patients had neonatal hypocalcemia. Fourteen patients had permanent hypoparathyroidism including seven (54%) of those above age 15 years. A history of neonatal hypocalcemia did not predict later occurring hypoparathyroidism. Parathyroid hormone levels were generally low indicating a low reserve capacity. Twenty-eight patients were positive for autoantibodies. Six (10%) persons had developed an autoimmune disease, and all were females (P<0.02). Hypoparathyroidism correlated with autoimmune diseases (P<0.05), however, no antibodies were detected against the parathyroid glands. CONCLUSIONS: Hypoparathyroidism and autoimmunity occur frequently in the 22q11.2 DS. Neonatal hypocalcemia is not associated with later development of permanent hypoparathyroidism. Hypoparathyroidism may present at any age, also in adults, and warrants regular measurement of calcium levels. Hypoparathyroidism and autoimmunity occur frequently together. Our findings of autoimmune diseases in 10% of the patients highlight the importance of stringent screening and follow-up routines.


Assuntos
Síndrome da Deleção 22q11/complicações , Síndrome da Deleção 22q11/epidemiologia , Doenças Autoimunes/complicações , Doenças Autoimunes/epidemiologia , Autoimunidade , Hipoparatireoidismo/complicações , Hipoparatireoidismo/epidemiologia , Síndrome da Deleção 22q11/imunologia , Adolescente , Adulto , Doenças Autoimunes/genética , Autoimunidade/genética , Autoimunidade/fisiologia , Criança , Pré-Escolar , Cromossomos Humanos Par 22 , Feminino , Humanos , Hipocalcemia/complicações , Hipocalcemia/congênito , Hipocalcemia/diagnóstico , Hipocalcemia/epidemiologia , Hipoparatireoidismo/genética , Hipoparatireoidismo/imunologia , Lactente , Masculino , Pessoa de Meia-Idade , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...